Previous close | 8.72 |
Open | 8.62 |
Bid | 8.63 x 0 |
Ask | 8.76 x 0 |
Day's range | 8.62 - 8.62 |
52-week range | 2.60 - 8.72 |
Volume | |
Avg. volume | 8 |
Market cap | 368.927M |
Beta (5Y monthly) | 1.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore Verrica Pharmaceuticals' financial performance, strategic partnerships, and operational insights from the first quarter of 2024.
Exploring Verrica's Financial Outcomes and Strategic Developments in the First Quarter
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of 29.63% and 41.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?